Inventor
Joseph L. Witztum
Inventor
San Diego, CA, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties31%
C07KPeptides23%
A61KPreparations for medical, dental or toiletry purposes21%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests12%
A01KAnimal husbandry4%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
C12NMicroorganisms or enzymes2%
PatentTitleYear
11,008,382Antibodies to oxidized phospholipids202111,008,381Antibodies to oxidized phospholipids20219,593,333'Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations'20179,518,088'Peptide-phospholipid conjugates'20169,347,959'Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (TIA) and peripheral arterial disease (PAD)'20169,075,050'Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios'20158,883,428'Methods to determine atherosclerosis regression, plaque stabilization and cardiovascular risk'20148,383,355'Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event'20138,361,732'Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event'20138,163,504'Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event'20128,129,123'Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios'20127,939,287'Methods of identifying a subject having or at risk of having or developing coronary artery disease'20117,575,873'Reagents for diagnosing, imaging and treating atherosclerotic disease'20097,556,927'Methods for diagnosing, imaging and treating atherosclerotic disease'20096,716,410'Reagents and methods for diagnosing, imaging and treating atherosclerotic disease'20046,375,925'Methods and reagents for non-invasive imaging of atherosclerotic plaque'20026,225,070'Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma'20015,786,206'DNA encoding recombinant lipoprotein antigens'19985,460,947'Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas'19955,408,038'Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides'19955,330,910'Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas'19945,169,937'Method for producing stable glycosylated hemoglobin'19924,876,188'Novel immunochemical method for assaying stable glycosylated hemoglobin'19894,828,986'Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample'19894,778,752'Receptors specific for hapten-modified self proteins'1988Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1988–2021Based in San Diego, CA, US· patent location history
1992–1998Patents assigned to SCRIPPS RESEARCH INST (5)· patent assignee history
2001–2021Patents assigned to UNIV CALIFORNIA (15)· patent assignee history
2012–2014Patents assigned to TSIMIKAS SOTIRIOS (5)· patent assignee history
2012–2013Patents assigned to INST NAT SANTE RECH MED (3)· patent assignee history
2012–2013Patents assigned to MALLAT ZIAD (3)· patent assignee history
2013Based in La Jolla, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV CALIFORNIA | 15 | 2001–2021 |
| SCRIPPS RESEARCH INST | 5 | 1992–1998 |
| TSIMIKAS SOTIRIOS | 5 | 2012–2014 |
| INST NAT SANTE RECH MED | 3 | 2012–2013 |
| MALLAT ZIAD | 3 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 24 | 1988–2021 |
| La Jolla, California, US | 1 | 2013 |